Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Sterling Biotech Ltd (STBI)

NSE
Currency in INR
Disclaimer
0.700
0.000(0.00%)
Closed
Fair Value
Unlock Value
Day's Range
0.6500.750
52 wk Range
0.0000.750
Bid/Ask
0.70 / 0.75
Prev. Close
0.7
Open
0.65
Day's Range
0.65-0.75
52 wk Range
0-0
Volume
0
Average Vol. (3m)
673,528
1-Year Change
0%
Shares Outstanding
143,334,400
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about STBI?
Vote to see community's results!
or

Sterling Biotech Ltd Company Profile

Sterling Biotech Limited is engaged in the manufacturing of pharma-grade gelatin and di-calcium phosphate and other pharma products. The Company manufactures gelatin from animal bones. It also manufactures gelatine and its derivatives, resinoids, glues, and allopathic pharmaceutical preparations. It offers anticancer products, such as DOXO Rubicin, which is an anti-cancer chemotherapy drug and is classified as an anthracycline antibiotic; IDARUBICIN, which is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug; Daunorubicinis, which is used to treat acute lymphocytic and myelocyticleukemias; IMATINIB, which is a drug used to treat certain cancers, and EPI Rubicin, which is an anthracycline drug used for chemotherapy. Its other products include Lovastatin, which is a cholesterol-lowering agent; DACARBAZINE, which is used to treat Hodgkin disease and malignant melanoma, and Simvastatin, which is a lipid-lowering drug used to decrease heart problems in those at a high risk.

Employees
801
Market
India
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.